Literature DB >> 25099103

Diplopia due to ocular motor cranial neuropathies.

Wayne T Cornblath.   

Abstract

PURPOSE OF REVIEW: Determining which cranial nerve(s) is (are) involved is a critical step in appropriately evaluating a patient with diplopia. RECENT
FINDINGS: New studies have looked at the various etiologies of cranial nerve palsies in the modern imaging era. The importance of the C-reactive protein test in evaluating the possibility of giant cell arteritis has recently been emphasized.
SUMMARY: Dysfunction of the oculomotor (third), trochlear (fourth), or abducens (sixth) cranial nerve will produce ocular misalignment and resultant binocular diplopia or binocular blur. A misalignment in the vertical plane of as small as 200 μm is enough to produce diplopia. Diagnosing diplopia from a cranial nerve abnormality requires an understanding of structure (the anatomy of the cranial nerves from nucleus to muscle), function (the movements controlled by the cranial nerves), possible etiologies, and exceptions to the rules.

Entities:  

Mesh:

Year:  2014        PMID: 25099103     DOI: 10.1212/01.CON.0000453309.44766.b4

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  4 in total

1.  Validation of clinical criteria for referral to head imaging in the neurologic emergency setting.

Authors:  Primož Žužek; Igor Rigler; Simon Podnar
Journal:  Neurol Sci       Date:  2019-07-17       Impact factor: 3.307

2.  Validity and reliability of the Ocular Motor Nerve Palsy Scale.

Authors:  Ling-Yun Zhou; Chang Su; Tie-Juan Liu; Xue-Mei Li
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

3.  Doctor, I'm Seeing Two of Everything.

Authors:  Alex Davis; Christopher M Lloyd
Journal:  Cureus       Date:  2020-01-08

4.  Acute binocular diplopia: peripheral or central?

Authors:  Olympia Kremmyda; Claudia Frenzel; Katharina Hüfner; Nicolina Goldschagg; Christian Brem; Jennifer Linn; Michael Strupp
Journal:  J Neurol       Date:  2020-08-14       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.